Uptake and timing of bilateral and contralateral risk-reducing mastectomy in women with Li–Fraumeni syndrome

[1]  A. Howell,et al.  Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in BRCA1, BRCA2, and TP53 Genes in Women with Very Early-Onset (<36 Years) Breast Cancer , 2020, Cancers.

[2]  J. Fraumeni,et al.  Reproductive factors associated with breast cancer risk in Li-Fraumeni syndrome. , 2019, European journal of cancer.

[3]  D. Bluemke,et al.  Prevalence of Cancer at Baseline Screening in the National Cancer Institute Li-Fraumeni Syndrome Cohort , 2017, JAMA oncology.

[4]  David M. Thomas,et al.  Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis , 2017, JAMA oncology.

[5]  E. Zabor,et al.  Differences Among a Modern Cohort of BRCA Mutation Carriers Choosing Bilateral Prophylactic Mastectomies Compared to Breast Surveillance , 2017, Annals of Surgical Oncology.

[6]  L. Strong,et al.  Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome , 2017, Clinical Cancer Research.

[7]  P. Rosenberg,et al.  Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohort , 2016, Cancer.

[8]  Jennifer L. Geurts,et al.  Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. , 2016, American journal of surgery.

[9]  Zicheng Xu,et al.  Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review , 2016, Clinical Cancer Research.

[10]  C. Bonaïti‐pellié,et al.  Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Soran,et al.  Decision Making and Factors Influencing Long-term Satisfaction With Prophylactic Mastectomy in Women With Breast Cancer , 2015, American journal of clinical oncology.

[12]  David B. Portnoy,et al.  Effects of false-positive cancer screenings and cancer worry on risk-reducing surgery among BRCA1/2 carriers. , 2014, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[13]  T. Raine-Bennett,et al.  Risk management options elected by women after testing positive for a BRCA mutation. , 2014, Gynecologic oncology.

[14]  C. Seynaeve,et al.  Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer , 2013, Familial Cancer.

[15]  S. Gruber,et al.  Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort , 2012, Breast Cancer Research and Treatment.

[16]  K. Kuntz,et al.  Perceptions of Contralateral Breast Cancer: An Overestimation of Risk , 2011, Annals of Surgical Oncology.

[17]  E. Warner,et al.  Reasons for risk-reducing mastectomy versus MRI-screening in a cohort of women at high hereditary risk of breast cancer. , 2011, Breast.

[18]  P. Rosenberg,et al.  Declining incidence of contralateral breast cancer in the United States from 1975 to 2006. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  L. Sunde,et al.  Risk‐reducing mastectomy and salpingo‐oophorectomy in unaffected BRCA mutation carriers: uptake and timing * , 2010, Clinical genetics.

[20]  U. Bick,et al.  Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Garber,et al.  Contralateral breast cancer in BRCA1/BRCA2 mutation carriers: the story of the other side. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  E. Vittinghoff,et al.  Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers. , 2009, Genetic testing and molecular biomarkers.

[23]  A. Werner-Lin,et al.  Beating the Biological Clock: The Compressed Family Life Cycle of Young Women with BRCA Gene Alterations , 2008, Social work in health care.

[24]  W. Otten,et al.  Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Jan Lubinski,et al.  International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers , 2008, International journal of cancer.

[26]  P. Møller,et al.  Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  F. Couch,et al.  Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. , 2007, Clinical breast cancer.

[28]  N. Facione,et al.  Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. , 2004, Preventive medicine.

[29]  D. Malkin.  Li-fraumeni syndrome. , 2001, Genes & cancer.

[30]  R. A'hern,et al.  The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews , 2001, BMJ : British Medical Journal.

[31]  D. Heron,et al.  Bilateral breast carcinoma , 2000, Cancer.

[32]  J. Struewing,et al.  Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. , 1995, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[33]  M. Daly,et al.  Attitudes about genetic testing for breast-ovarian cancer susceptibility. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  L. Norton,et al.  Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  L. Tanoue,et al.  The National Comprehensive Cancer Network , 1998, Cancer.

[36]  J. Klijn,et al.  The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy. , 2007, European journal of cancer.